4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000008
President and CEO acquired 89,520 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2024-01-03 | Grant or award | +89,520 | 272,957 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2024-01-03 | Grant or award · Stock Option (right to buy) | +268,560 | 268,560 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1704495377.xml…